TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
press enter to search

LOG IN / REGISTER
TJP Logo
The Jakarta Post - Logo Mobile

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

COVID-19-drugs

Takeda-led COVID-19 plasma treatment unlikely to meet July goal of trial start
World 4 years ago

Takeda-led COVID-19 plasma treatment unlikely to meet July goal of trial start

A group led by Takeda Pharmaceutical Co have completed test supplies of a blood plasma treatment for...
Germany: Coronavirus vaccine unlikely to be widely available before mid-2021
World 4 years ago

Germany: Coronavirus vaccine unlikely to be widely available before mid-2021

Germany awarded three biotech companies grants to help them speed up the development of coronavirus ...
S. Korea's Green Cross seeks phase 2 trials of COVID-19 plasma drug
World 4 years ago

S. Korea's Green Cross seeks phase 2 trials of COVID-19 plasma drug

South Korea's Green Cross Corp has sought regulatory approval for Phase II trials of an experime...
Canada OKs remdesivir for use against coronavirus
World 4 years ago

Canada OKs remdesivir for use against coronavirus

Canada on Tuesday gave the green light for people with severe symptoms of COVID-19 to be treated wit...
Glenmark's favipiravir version shows promise in late-stage COVID-19 trial
World 4 years ago

Glenmark's favipiravir version shows promise in late-stage COVID-19 trial

India's Glenmark Pharmaceuticals Ltd said on Wednesday its version of anti-flu drug favipiravir ...
Japan approves dexamethasone as coronavirus treatment
World 4 years ago

Japan approves dexamethasone as coronavirus treatment

Japan's health ministry has approved dexamethasone, a cheap and widely used steroid, as a second...
South Korea approves human trials of Celltrion's COVID-19 antibody drug
World 4 years ago

South Korea approves human trials of Celltrion's COVID-19 antibody drug

South Korea on Friday approved an early stage clinical trial of Celltrion Inc's experimental COV...
Hydroxychloroquine ineffective against mild COVID-19, US study shows
World 4 years ago

Hydroxychloroquine ineffective against mild COVID-19, US study shows

The anti-malaria drug touted by US President Donald Trump as a COVID-19 treatment was ineffective fo...
One in three South Korean COVID-19 patients improve with remdesivir
World 4 years ago

One in three South Korean COVID-19 patients improve with remdesivir

One in three South Korean patients seriously ill with COVID-19 showed an improvement in their condit...
EU scrambles to buy intensive care drugs to tackle COVID shortages
World 5 years ago

EU scrambles to buy intensive care drugs to tackle COVID shortages

The European Union is seeking firms to supply 24 intensive care drugs, an EU official told Reuters, ...
The Jakarta Post - Premium Subscription Banner
The Jakarta Post
The Jakarta Post - Apps Store Icon The Jakarta Post - Google Play Icon

© 2016 - 2025 PT. Bina Media Tenggara